Aslan Pharmaceuticals | D:發行公告
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Mitchell P. Kopin(4.4%),Daniel B. Asher(4.4%)等
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%)等
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-K2 HealthVentures Equity Trust LLC(5.2%),Parag Shah(5.2%)等
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BVF Partners L.P.(9.99%),BVF Inc.(9.99%)等
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(1.5%),Tang Capital Management, LLC(1.5%)等
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(11.0%),Tang Capital Management, LLC(11.0%)等
Aslan Pharmaceuticals | D:發行公告
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-K2 HealthVentures Equity Trust LLC(6.2%),Parag Shah(6.2%)等
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BVF Partners L.P.(9.99%),BVF Inc.(9.99%)等
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(7.8%),Tang Capital Management, LLC(7.8%)等
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-RTW Investments, LP(0%),Roderick Wong(0%)
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-TANG CAPITAL PARTNERS, LP(5.4%),Tang Capital Management, LLC(5.4%)等
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-RTW Investments, LP(6.8%),Roderick Wong(6.8%)
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件
暫無數據